HuGE Literature Finder
Records 1-21
|
A novel C2 domain binding CD33xCD3 bispecific antibody with potent T-cell redirection activity against acute myeloid leukemia.
Blood advances 2020 Mar 4 (5): 906-919. Nair-Gupta Priyanka, Diem Michael, Reeves Dara, Wang Weirong, Schulingkamp Robert, Sproesser Katrin, Mattson Bethany, Heidrich Bradley, Mendonça Mark, Joseph Jocelin, Sendecki Jocelyn, Foulk Brad, Chu Gerald, Fink Damien, Jiao Qun, Wu Sheng-Jiun, Packman Kathryn, Elsayed Yusri, Attar Ricardo, Gaudet Franço |
|
Donor KIR2DS1 reduces the risk of transplant related mortality in HLA-C2 positive young recipients with hematological malignancies treated by myeloablative conditioning.
PloS one 2019 14 (6): e0218945. Tordai Attila, Bors Andras, Kiss Katalin Piroska, Balassa Katalin, Andrikovics Hajnalka, Batai Arpad, Szilvasi Aniko, Rajczy Katalin, Inotai Dora, Torbagyi Eva, Lengyel Lilla, Barta Aniko, Remenyi Peter, Masszi Tam |
|
[Association of genetic polymorphisms of KIR-HLA system with chronic myeloid leukemia among ethnic Hans from southern China].
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2017 Feb 34 (1): 53-57. Deng Zhihui, Zhen Jianxin, Wang Daming, He Liumei, Zou Hongy |
|
Recipient HLA-C Haplotypes and miRNA 148a/b Binding Sites Have No Impact on Allogeneic Hematopoietic Cell Transplantation Outcomes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2016 Oct . Hoff Gretchen A, Fischer Johannes C, Hsu Katharine, Cooley Sarah, Miller Jeffrey S, Wang Tao, Haagenson Michael, Spellman Stephen, Lee Stephanie J, Uhrberg Markus, Venstrom Jeffrey M, Verneris Michael |
|
The effect of missing KIR ligands, activating KIR genotype and haplotype on the outcome of T-cell-replete hematopoietic stem cell transplantation from HLA-identical siblings in Thai patients.
HLA 2016 Jun 87 (6): 422-31. Khanuntong S, Kuptawintu P, Upaisilpsathaporn K, Poolchareon A, Bunworasate U, Hirankarn |
|
KIR repertory in patients with hematopoietic diseases and healthy family members.
BMC hematology 2016 16 25. Sugioka Daniele Kazue, Gonçalves Carlos Eduardo Ibaldo, Bicalho Maria da Gra |
|
KIR-HLA profiling shows presence of higher frequencies of strong inhibitory KIR-ligands among prognostically poor risk AML patients.
Immunogenetics 2015 Dec . Shen Meixin, Linn Yeh-Ching, Ren Ee-Ch |
|
Genetic associations of killer immunoglobulin like receptors and class I human leukocyte antigens on childhood acute lymphoblastic leukemia among north Indians.
Human immunology 2015 Oct . Misra Maneesh Kumar, Prakash Swayam, Moulik Nirmalya Roy, Kumar Archana, Agrawal Suraks |
|
Impact of KIR and HLA Genotypes on Outcomes after Reduced-Intensity Conditioning Hematopoietic Cell Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2015 Sep 21 (9): 1589-96. Sobecks Ronald M, Wang Tao, Askar Medhat, Gallagher Meighan M, Haagenson Michael, Spellman Stephen, Fernandez-Vina Marcelo, Malmberg Karl-Johan, Müller Carlheinz, Battiwalla Minoo, Gajewski James, Verneris Michael R, Ringdén Olle, Marino Susana, Davies Stella, Dehn Jason, Bornhäuser Martin, Inamoto Yoshihiro, Woolfrey Ann, Shaw Peter, Pollack Marilyn, Weisdorf Daniel, Milller Jeffrey, Hurley Carolyn, Lee Stephanie J, Hsu Kathari |
|
KIR and HLA genotypes predictive of low-affinity interactions are associated with lower relapse in autologous hematopoietic cell transplantation for acute myeloid leukemia.
Journal of immunology (Baltimore, Md. : 1950) 2015 May 194 (9): 4222-30. Marra John, Greene Justin, Hwang Jimmy, Du Juan, Damon Lloyd, Martin Tom, Venstrom Jeffrey |
|
KIR ligand C2 is associated with increased susceptibility to childhood ALL and confers an elevated risk for late relapse.
Blood 2014 Oct 124 (14): 2248-51. Babor Florian, Manser Angela R, Fischer Johannes C, Scherenschlich Nadine, Enczmann Jürgen, Chazara Olympe, Moffett Ashley, Borkhardt Arndt, Meisel Roland, Uhrberg Mark |
|
The role of KIR genes and their cognate HLA class I ligands in childhood acute lymphoblastic leukemia.
Blood 2014 Apr 123 (16): 2497-503. de Smith Adam J, Walsh Kyle M, Ladner Martha B, Zhang Siming, Xiao Carmen, Cohen Franziska, Moore Theodore B, Chokkalingam Anand P, Metayer Catherine, Buffler Patricia A, Trachtenberg Elizabeth A, Wiemels Joseph |
|
Donor selection for killer immunoglobulin-like receptors B haplotype of the centromeric motifs can improve the outcome after HLA-identical sibling hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2014 Jan 20 (1): 98-105. Zhou Huifen, Bao Xiaojing, Wu Xiaojin, Tang Xiaowen, Wang Miao, Wu Depei, He J |
|
Donor selection for KIR B haplotype of the centromeric motifs can improve the outcome after HLA-identical sibling hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013 Oct . Zhou Huifen, Bao Xiaojing, Wu Xiaojin, Tang Xiaowen, Wang Miao, Wu Depei, He J |
|
Inhibitory KIR/HLA incompatibility between sexual partners confers protection against HIV-1 transmission.
Blood 2013 Feb 121 (7): 1157-64. Jennes Wim, Verheyden Sonja, Mertens Julie W, Camara Makhtar, Seydi Moussa, Dieye Tandakha N, Mboup Souleymane, Demanet Christian, Kestens L |
|
The impact of HLA-C matching depends on the C1/C2 KIR ligand status in unrelated hematopoietic stem cell transplantation.
Immunogenetics 2012 Dec 64 (12): 879-85. Fischer Johannes C, Kobbe Guido, Enczmann Jürgen, Haas Rainer, Uhrberg Mark |
|
Role of killer immunoglobulin-like receptor-ligand interactions in human leukocyte antigen-matched sibling hematopoietic stem cell transplantation.
Transplantation proceedings 2012 May 44 (4): 919-21. Kanga U, Mourya M, Seth T, George J, Sood P, Sharma R, Saxena A, Mehra N |
|
KIR/HLA gene combinations influence susceptibility to B-cell chronic lymphocytic leukemia and the clinical course of disease.
Tissue antigens 2011 Aug 78 (2): 129-38. Karabon L, Jedynak A, Giebel S, Wo?owiec D, Kielbinski M, Woszczyk D, Kapelko-Slowik K, Kuliczkowski K, Frydecka |
|
[Relation of GSTP1 and CYP2E1 polymorphisms with susceptibility to acute leukemia].
Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology 2011 Jun 19 (3): 589-93. Xi Ya-Ming, Shi Xiu-E, Zhang Hao, Jia Ming-Feng, Li Ming, Li Pei, Xu Jian-Wang, Ma Hai-Zhen, Yao Xiao-Ji |
|
Does the KIR2DS5 gene protect from some human diseases?
PloS one 2010 5 (8): e12381. Nowak Izabela, Majorczyk Edyta, Wi?niewski Andrzej, Pawlik Andrzej, Magott-Procelewska Maria, Passowicz-Muszy?ska Ewa, Malejczyk Jacek, P?oski Rafa?, Giebel Sebastian, Barcz Ewa, Zo?-Giebel Aleksandra, Malinowski Andrzej, Tchórzewski Henryk, Chlebicki Arkadiusz, ?uszczek Wioleta, Kurpisz Maciej, Grybo? Marian, Wilczy?ski Jacek, Wiland Piotr, Senitzer David, Sun Ji-Yao, Jankowska Renata, Klinger Marian, Ku?nierczyk Pio |
|
High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia.
Blood 2009 Jul 114 (3): 647-50. Gutierrez Alejandro, Sanda Takaomi, Grebliunaite Ruta, Carracedo Arkaitz, Salmena Leonardo, Ahn Yebin, Dahlberg Suzanne, Neuberg Donna, Moreau Lisa A, Winter Stuart S, Larson Richard, Zhang Jianhua, Protopopov Alexei, Chin Lynda, Pandolfi Pier Paolo, Silverman Lewis B, Hunger Stephen P, Sallan Stephen E, Look A Thom |
- Page last reviewed:Oct 1, 2020
- Page last updated:Nov 24, 2020
- Content source: